ClinicalTrials.Veeva

Menu

A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Pfizer logo

Pfizer

Status

Completed

Conditions

SARS-CoV-2 Infection

Treatments

Drug: nirmatrelvir / ritonavir

Study type

Observational

Funder types

Industry

Identifiers

NCT05263908
C4671018

Details and patient eligibility

About

The purpose of this post marketing observational study is to learn about the safety and effects of the commercial medicine (called PAXLOVID) for the treatment of COVID-19. This study is intended to be registered with the participants who:

  • Have taken PAXLOVID PACK and have no history of using this medicine.
  • Are 12 years and older

All participants will receive PAXLOVID, a standard treatment for COVID-19. Participants will take PAXLOVID 2 times a day by mouth or as prescribed.

We will examine the experiences of people taking PAXLOVID. This will help us determine if PAXLOVID is safe and effective.

Participants will be followed up for 28 days after taking PAXLOVID. During this time, participants will be closely watched for the safety and effects of PAXLOVID.

Full description

This is a multicenter cohort study to be conducted in individuals with SARS-CoV-2 infection who are treated with this product, and the investigator will enter the information required in this study in the case report forms (CRFs) based on the information obtained through medical records.

Enrollment

3,346 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects who are administered PAXLOVID PACK and have no history of using this drug.

Exclusion criteria

  • There are no exclusion criteria for this study.

Trial design

3,346 participants in 1 patient group

PAXLOVID PACK
Description:
Subjects administered PAXLOVID PACK
Treatment:
Drug: nirmatrelvir / ritonavir

Trial contacts and locations

1

Loading...

Central trial contact

Pfizer CT.gov Call Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems